Skip to main content
Fig. 7 | BMC Bioinformatics

Fig. 7

From: An integrated meta-analysis approach to identifying medications with potential to alter breast cancer risk through connectivity mapping

Fig. 7

Comparison of significant drugs obtained from the equal-distance division sub-signatures versus those from systematic 5-fold random division sub-gene signatures. Blue ellipse: The set of drugs that are significantly connected to 3 out of 5 of equal-distance division sub-signatures in the connectivity mapping analysis. Red ellipse: The top 33 drugs from the equal-distance division method of sub-signatures. This is a set of drugs reported in Table 2; Green ellipse: Result obtained from 20 repeats of the random division of sub-signatures. Enclosed in this ellipse are drugs that are significant in 19 out of the 20 runs (95%); Yellow ellipse: Result obtained from another 40 repeats of the random division of sub-signatures. Enclosed in this ellipse are drugs that are significant in 38 out of the 40 runs (95%)

Back to article page